DUBLIN, April 26, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Immunoassay Systems - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments:
- Enzyme Immunoassay
- Fluorescence Immunoassay
- Chemiluminescence Immunoassay
- Rapid Tests
- ELISPOT
- PCR
- Others.
The report profiles 65 companies including many key and niche players such as:
- Abbott Laboratories (USA)
- Beckman Coulter, Inc. (USA)
- bioMérieux SA (France)
- Bio-Rad Laboratories Inc. (USA)
- DiaSorin S.p.A (Italy)
- Fujirebio, Inc. (Japan)
- Ortho-Clinical Diagnostics, Inc. (USA)
- Roche Diagnostics (Switzerland)
- Siemens Healthineers (USA)
- Sysmex Corporation (Japan)
- Quidel Corporation (USA)
- Tosoh Bioscience, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Immunoassays
- A Preface
- Current and Future Analysis
- Factors Sustaining Market Growth
- Factors Restraining Growth
- Developing Markets to Drive Sales
- Radioimmunoassay Systems Lose Ground
- Chemiluminescence Immunoassays Gain Demand
- Expanding Immunoassay Applications Boost Demand
2. COMPETITIVE LANDSCAPE
3. MARKET TRENDS AND ISSUES
- Bespoke Solutions Energize Market Growth
- Multiplex Immunoassays Grow in Demand
- Novel Biomarkers to Boost Market Growth
- SERS
- An Attractive Readout Strategy
- Automated Immunoassay Systems
- In Line with Automation Trend
- Technological Advances to buoy ELISA's Prospects
- Automation of ELISA
- Enabling its Sustenance
- Growing Popularity of Multiplexing Deters ELISA Market
- Commoditization: A Key Issue Facing ELISA Product Manufacturers
- Consolidation of Hospitals and Labs Drives Demand
- POC and DIA Systems Grow in Demand
- Prenatal Testing
- An Opportunity Market
- Rise in Infectious Diseases Raises Demand
- Increasing Use of Immunoassays in Food Sciences and Quality Control
- Growing Use in Environmental Testing
4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS
- Improving Healthcare Expenditure to Foster Growth
- Blood Processing Market
- Cancer Testing Markets
- Drugs of Abuse Testing Market
- Therapeutic Drug Monitoring
- Immune Disease
- Blood Grouping and Typing
5. CONCEPTUAL OVERVIEW
6. PRODUCT LAUNCHES/APPROVALS
- Sekisui Diagnostics Launches new SEKURE® TPLA and RPR Assays for Syphilis Testing
- Siemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer System
- Abbott Introduces Alinity
- Roche Introduces New Cobas e 801 Module
- Siemens to Release Genetic Assay for Detection of Zika Virus
- Fujirebio Europe Releases the Lumipulse G B - R - A - H - M - S PCT Assay
- Fujirebio Releases "Lumipulse L 2400" CLIA System
- Roche Introduces Elecsys® HTLV-I/II Immunoassay
- Siemens Introduces ADVIA Centaur Syphilis Assay
- Sysmex Introduces HISCL-800 Automated Immunoassay System
- Siemens Introduces New Chemistry & Immunoassay Systems
- Meso Scale Discovery Launches S-PLEX Assays
- Modern Water Monitoring Introduces New Immunoassay Strip Test and Readers
- Enzo Life Sciences Launches Amp'd ELISA Signal Amplification Kit
- EMD Millipore Rolls Out New Immunoassay Kits
- PerkinElmer Launches Novel Research Tools
- Roche Releases Elecsys Syphilis Immunoassay
7. RECENT INDUSTRY ACTIVITY
- Abbott Receives CE Mark for Alinity CI-Series Diagnostic Systems
- Quidel Receives FDA Clearance for New Solana(R) Molecular Assay
- Quidel Receives FDA Clearance for Solana(R) Strep Complete Assay
- FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs
- Beckman Coulter Receives FDA Clearance for Access TSH (3rd IS) Assay
- Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
- Ortho Clinical Diagnostics Receives CE Mark Approval for VITROS® Immunodiagnostic HIV Combo Test
- Siemens Healthcare Changes Name to Siemens Healthineers
- DiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product Business
- Quidel Receives CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent Immunoassay
- DiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in China
- bioMérieux Receives FDA 510(k) clearance for VIDAS® 3
- Quidel Receives FDA Clearance for New Solana Molecular System and Solana Molecular Assay
- Siemens Receives FDA Approval for Siemens HIV Combo assay
- Eurofins Acquired ViraCor-IBT Laboratories
- YSL Bio Signs Enters into Agreement with GeneX
- Techne to Acquire CyVek
- Gyros Enters into Distribution Agreement with Tekon Biotech
- Singulex Partners with Tecan
- OriGene Technologies Takes Over BioCheck
- Techne Partners with Fisher Scientific
8. FOCUS ON SELECT MARKET PARTICIPANTS
9. GLOBAL MARKET PERSPECTIVE
For more information about this report visit http://www.researchandmarkets.com/research/rs4bzt/immunoassay
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article